Treatment with Tafinlar in combination with Mekinist showed what researchers described as “considerable efficacy” among ...

The Union Budget 2025-26 introduces key healthcare measures, including the exemption of 36 life-saving drugs from Basic ...

Select listed pharma player including Pfizer, Novartis India, AstraZeneca Pharma and GSK Pharma shall be the beneficiaries of ...

Dr. Blackman co-founded Day One Biopharmaceuticals in 2018 with a vision to identify, acquire, and develop promising new treatments to address childhood cancers. Under Dr. Blackman’s leadership, Day ...

Budget 2025: Seeks to further amend notification No. 16/2017-Customs, dated the 20th April, 2017 so to exempt certain drugs for supply under Patient Assistance Programme run by specified ...

These therapies may be used as single agents or in combination. Some targeted therapies for pLGGs include dabrafenib (Tafinlar), tovorafenib (Ojemda), and trametinib (Mekinist). Your health care ...

This research aims to create dabrafenib (DBF)-loaded nanosponges (NSPs) using β-cyclodextrin (β-CD) and diphenyl carbonate (DPC) as linker to improve oral bioavailability. DBF-loaded β-CD NSPs were ...

During 2024, the radiopharmaceutical Pluvicto achieved blockbuster status, while sales of the breast cancer drug Kisqali grew 46 percent compared to 2023.

In another study, the composition of renal deposits in rat kidneys was analyzed following oral administration of dabrafenib, an ATP-competitive inhibitor of RAF kinase activity, using a combination of ...